{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:58:42Z","timestamp":1740135522274,"version":"3.37.3"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T00:00:00Z","timestamp":1718409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T00:00:00Z","timestamp":1718409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Carcinoma in situ of the bladder is a high-grade cancer that originates in the superficial layer of the bladder. It has the potential to invade nearby organs, and it can spread through blood and lymphatic circulation to distant parts of the body.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 58-year-old non-smoker male presented with gross and microscopic hematuria. His family history included his father\u2019s recent bladder cancer. Initial investigations showed hematuria, inflammation, negative urine culture, digital rectal examination revealed an enlarged right lobe of the prostate, and an elevated Prostate-Specific Antigen level. Histopathological examination of samples taken from the bladder mucosa and the prostate confirmed urothelial carcinoma in situ in the bladder and prostate. Further evaluation revealed no other metastasis. The tumor was classified as T4aN0M0. The patient underwent radical cystoprostatectomy and histopathological examination showed that the tumor invading the muscularis propria of the bladder as well as the prostatic glands, but no malignancy was found in prostatic urethra and other areas. The patient was discharged three weeks post-operation and completed on adjuvant chemotherapy consisting of Gemcitabine, and Cisplatin to prevent of relapse. The patient is currently in a good healthy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The occurrence of bladder cancer metastasizing to the prostate without involving the prostatic urethra is uncommon and requires precise diagnostic techniques for accurate tumor classification. Early management is advised to enhance the prognosis for the patient.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12894-024-01516-6","type":"journal-article","created":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T09:01:44Z","timestamp":1718442104000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Carcinoma in situ within the bladder trigone with an isolated metastasis to the prostate without involvement of prostatic urethra: a unique case report"],"prefix":"10.1186","volume":"24","author":[{"given":"Omran","family":"Batha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7034-0988","authenticated-orcid":false,"given":"Ahmed","family":"Aldolly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6651-1762","authenticated-orcid":false,"given":"Yousef","family":"Alsaffaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0994-1829","authenticated-orcid":false,"given":"Suaad","family":"Hamsho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Atia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fayez","family":"Salmeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louei","family":"Alia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,15]]},"reference":[{"issue":"4","key":"1516_CR1","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.euf.2019.03.012","volume":"6","author":"JD Subiela","year":"2020","unstructured":"Subiela JD, Rodr\u00edguez Faba O, Guerrero Ramos F, Vila Reyes H, Pisano F, Breda A, Palou J. Carcinoma in situ of the urinary bladder: a systematic review of current knowledge regarding detection, treatment, and outcomes. Eur Urol Focus. 2020;6(4):674\u201382. Epub 2019 Mar 23. PMID: 30910393.","journal-title":"Eur Urol Focus"},{"issue":"5","key":"1516_CR2","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.eururo.2014.10.040","volume":"67","author":"RG Casey","year":"2015","unstructured":"Casey RG, Catto JW, Cheng L, Cookson MS, Herr H, Shariat S, Witjes JA, Black PC. Diagnosis and management of urothelial carcinoma in situ of the lower urinary tract: a systematic review. Eur Urol. 2015;67(5):876\u201388. https:\/\/doi.org\/10.1016\/j.eururo.2014.10.040. Epub 2014 Nov 14. PMID: 25466937.","journal-title":"Eur Urol"},{"key":"1516_CR3","unstructured":"Pasin E, Josephson DY, Mitra AP, Cote RJ, Stein JP. Superficial bladder cancer: an update on etiology, molecular development, classification, and natural history. Rev Urol 2008 Winter;10(1):31\u201343. PMID: 18470273; PMCID: PMC2312342."},{"key":"1516_CR4","doi-asserted-by":"publisher","unstructured":"MELICOW MM. Histological study of vesical urothelium intervening between gross neoplasms in total cystectomy. J Urol. 1952;68(1):261\u2009\u2013\u200979. https:\/\/doi.org\/10.1016\/S0022-5347(17)68193-X. PMID: 14939458.","DOI":"10.1016\/S0022-5347(17)68193-X"},{"issue":"12","key":"1516_CR5","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1002\/ijc.33486","volume":"148","author":"S Koutros","year":"2021","unstructured":"Koutros S, Decker KL, Baris D, Pardo LA, Johnson A, Hosain GMM, Rothman N, Karagas MR, Schwenn MR, Silverman DT. Bladder cancer risk associated with family history of cancer. Int J Cancer. 2021;148(12):2915\u201323. https:\/\/doi.org\/10.1002\/ijc.33486. Epub 2021 Mar 5. PMID: 33506540; PMCID: PMC10294142.","journal-title":"Int J Cancer"},{"issue":"571","key":"1516_CR6","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3399\/bjgp10X483175","volume":"60","author":"W Hamilton","year":"2010","unstructured":"Hamilton W. Cancer diagnosis in primary care. Br J Gen Pract. 2010;60(571):121\u20138. https:\/\/doi.org\/10.3399\/bjgp10X483175. PMID: 20132704; PMCID: PMC2814263.","journal-title":"Br J Gen Pract"},{"key":"1516_CR7","doi-asserted-by":"publisher","unstructured":"Shephard EA, Stapley S, Neal RD, Rose P, Walter FM, Hamilton WT. Clinical features of bladder cancer in primary care. Br J Gen Pract. 2012;62(602):e598-604. https:\/\/doi.org\/10.3399\/bjgp12X654560. Erratum in: Br J Gen Pract. 2014;64(620):126. PMID: 22947580; PMCID: PMC3426598.","DOI":"10.3399\/bjgp12X654560"},{"issue":"6","key":"1516_CR8","first-page":"1145","volume":"63","author":"GD Grossfeld","year":"2001","unstructured":"Grossfeld GD, Wolf JS Jr, Litwan MS, Hricak H, Shuler CL, Agerter DC, Carroll PR. Asymptomatic microscopic hematuria in adults: summary of the AUA best practice policy recommendations. Am Fam Physician. 2001;63(6):1145\u201354. PMID: 11277551.","journal-title":"Am Fam Physician"},{"issue":"3","key":"1516_CR9","doi-asserted-by":"publisher","first-page":"761","DOI":"10.3390\/jcm11030761","volume":"11","author":"P Adamczyk","year":"2022","unstructured":"Adamczyk P, Pob\u0142ocki P, Kadlubowski M, Ostrowski A, Wr\u00f3bel A, Miko\u0142ajczak W, Adamowicz J, Drewa T, Juszczak K. A Comprehensive Approach to clinical staging of bladder Cancer. J Clin Med. 2022;11(3):761. https:\/\/doi.org\/10.3390\/jcm11030761. PMID: 35160213; PMCID: PMC8836507.","journal-title":"J Clin Med"},{"key":"1516_CR10","doi-asserted-by":"publisher","unstructured":"Herr HW. Extravesical tumor relapse in patients with superficial bladder tumors. J Clin Oncol. 1998;16(3):1099\u2009\u2013\u2009102. https:\/\/doi.org\/10.1200\/JCO.1998.16.3.1099. PMID: 9508196.","DOI":"10.1200\/JCO.1998.16.3.1099"},{"issue":"3","key":"1516_CR11","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.ucl.2016.04.012","volume":"43","author":"L Aaron","year":"2016","unstructured":"Aaron L, Franco OE, Hayward SW. Review of prostate anatomy and embryology and the etiology of Benign Prostatic Hyperplasia. Urol Clin North Am. 2016;43(3):279\u201388. https:\/\/doi.org\/10.1016\/j.ucl.2016.04.012. PMID: 27476121; PMCID: PMC4968575.","journal-title":"Urol Clin North Am"},{"issue":"8","key":"1516_CR12","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1074\/jbc.REV119.007759","volume":"295","author":"M Janiszewska","year":"2020","unstructured":"Janiszewska M, Primi MC, Izard T. Cell adhesion in cancer: beyond the migration of single cells. J Biol Chem. 2020;295(8):2495\u2013505. https:\/\/doi.org\/10.1074\/jbc.REV119.007759. Epub 2020 Jan 14. PMID: 31937589; PMCID: PMC7039572.","journal-title":"J Biol Chem"},{"issue":"7","key":"1516_CR13","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1016\/j.humpath.2014.02.023","volume":"45","author":"Y Liang","year":"2014","unstructured":"Liang Y, Heitzman J, Kamat AM, Dinney CP, Czerniak B, Guo CC. Differential expression of GATA-3 in urothelial carcinoma variants. Hum Pathol. 2014;45(7):1466\u201372. https:\/\/doi.org\/10.1016\/j.humpath.2014.02.023. Epub 2014 Mar 15. PMID: 24745616.","journal-title":"Hum Pathol"},{"issue":"1","key":"1516_CR14","doi-asserted-by":"publisher","first-page":"84","DOI":"10.4103\/0970-1591.38609","volume":"24","author":"MV Khochikar","year":"2008","unstructured":"Khochikar MV. Treatment of locally advanced and metastatic bladder cancer. Indian J Urol. 2008;24(1):84\u201394. https:\/\/doi.org\/10.4103\/0970-1591.38609. PMID: 19468366; PMCID: PMC2684248.","journal-title":"Indian J Urol"},{"key":"1516_CR15","doi-asserted-by":"crossref","unstructured":"Herr HW, Donat SM. Prostatic tumor relapse in patients with superficial bladder tumors: 15-year outcome. J Urol. 1999;161(6):1854-7. PMID: 10332452.","DOI":"10.1016\/S0022-5347(05)68826-X"},{"key":"1516_CR16","doi-asserted-by":"publisher","unstructured":"von der Maase H, Sengelov L, Roberts JT, Ricci S, Dogliotti L, Oliver T, Moore MJ, Zimmermann A, Arning M. Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer. J Clin Oncol. 2005;23(21):4602-8. https:\/\/doi.org\/10.1200\/JCO.2005.07.757. PMID: 16034041.","DOI":"10.1200\/JCO.2005.07.757"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-024-01516-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-024-01516-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-024-01516-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T09:02:37Z","timestamp":1718442157000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcurol.biomedcentral.com\/articles\/10.1186\/s12894-024-01516-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,15]]},"references-count":16,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1516"],"URL":"https:\/\/doi.org\/10.1186\/s12894-024-01516-6","relation":{},"ISSN":["1471-2490"],"issn-type":[{"type":"electronic","value":"1471-2490"}],"subject":[],"published":{"date-parts":[[2024,6,15]]},"assertion":[{"value":"25 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal on request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"127"}}